Clinical ophthalmology, in working detail.
EyePod Bayer treats ophthalmology as a working clinical field, not a general-health curiosity. Recent conversations move between medical retina, AMD from the patient perspective, conjunctival and uveal tumors, refractive surgery, hospital development, and the realities of opening an eye clinic.
PRESS PLAY
EyePod Bayer is a specialist show about ophthalmology as it is practiced, taught, organized, and debated by people working close to the field. The recent run is heavily clinical. Medical retina appears through discussions of AMD, injections, OCT, OCT-A, angiography, laser, emerging treatments, and the importance of teams when cases are not simply black and white. One episode frames medical retina as a subspecialty shaped by education, research, technology, and collaboration. Another approaches AMD through Tord Jonsson, described as a doctor and retina specialist who has AMD himself. That gives the condition a patient-facing angle without turning the show into general self-help. The surgical episodes are more procedural. With Johan Germundsson named in the titles, the series covers refractive surgery, laser techniques, refractive lens exchange, intraocular options, patient selection, exclusion criteria, complications, and expected outcomes. The tumor episodes sharpen the diagnostic register. Charlotta All-Eriksson’s conversations cover conjunctival tumors, uveal tumors, uveal melanoma, nevi, metastasis, risk factors, biopsy choices, imaging, and when referral should happen. The show also looks beyond single diagnoses. Sten Kjellström’s episode brings in S:t Eriks ögonsjukhus, high-volume injection care, home monitoring, AI, digitalized care solutions, and vision impairment in daily life. Markus Karlsson’s episode moves into the mechanics of starting an eye clinic, including regional agreements, private care models, geography, capacity, and flexibility. The pacing is interviewer-led and pragmatic. Questions tend to ask for distinctions, criteria, risks, and summaries. The result is a focused professional resource: precise enough for eye-care contexts, but still shaped as conversation rather than lecture notes.
Made for: Suits a listener who wants ophthalmology discussed at a professional level, especially around retina, tumors, refractive surgery, and eye-care organization. It is best for someone comfortable with clinical vocabulary and Swedish-English medical conversation.
What sets it apart: EyePod Bayer stands apart by pairing subspecialty clinical detail with operational eye-care questions, moving from AMD and ocular tumors to hospital strategy and clinic startup decisions. Its strongest value is the practical texture of clinician-to-clinician interviewing.
Det här är en Podcast som drivs av Bayer Oftalmologi med inbjudna föreläsare, för alla er som är verksamma inom ögonsjukvården. Om du vill rapportera en misstänkt biverkning eller reklamation, klicka här eller besök oss på Bayers websida, Bayer.se under Kontakta oss och Anmälan av misstänkt biverkning. Hosted on Acast. See acast.com/privacy for more information.
An uncertain eye lesion calls for a photo and another opinion; your caution has found its people.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A grounded look at medical retina through education, imaging, teamwork, and patient-centered judgment.
Medical retina comes across here as a specialty shaped by teaching, research, technology, and the habits of a strong clinical team. Dr. Emad, a specialist doctor at Sahlgrenska University Hospital, links his path to the influence of Dr.
A clear, practical look at how anatomy, recovery, and preference shape refractive surgery choices.
Refractive surgery is framed as a careful fit between procedure and eye, rather than a simple choice between two familiar names. Dr. Johan Germansson traces how training in ophthalmology, corneal laser research, cataract surgery, and corneal transplants led him toward surgery,…
Brain science before it becomes a headline.
Dr.
EyePod Bayer intervjuar S:t Eriks vd Sten Kjellström om ögonsjukvårdens kapacitet i Hagastaden och Sverige.
EyePod Bayer interviews refractive surgeon Johan Germundsson about corneal laser procedures, patient selection, complications, outcomes, and future techniques.
Charlotta All-Eriksson identifies choroidal metastasis as a key differential, noting over 30% of cases precede systemic cancer diagnosis.
Charlotta All-Eriksson says primary acquired melanosis is often monitored too long instead of treated.
Karlsson advises starting a company years early so it is creditworthy when loans and leasing are needed.
More than 30 studies put glaucoma drop compliance between 10 and 80 percent, most around 40 percent.
An interview discussing the use of confocal microscopy to detect neurological deficits in the cornea, including neurotrophic ulcers and herpes simplex.
This episode discusses the virtual EURETINA 2020 congress, featuring interviews with ophthalmologists about the virtual format and key presentations.
An interview with the CEOs of LEAF and Bayer Scandinavia discussing the pharmaceutical industry's organization, priorities, and collaboration with healthcare.
An interview with Professor Paolo Lanzetta discussing ophthalmology guidelines and his work in vitreo-retinal diseases.